#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16392	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2539	783.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1674	1674	C	1071	C,T	1070,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28054	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4106	852.9	0	.	n	.	0	T695C	SNP	695	695	T	1341	1341	C	1027	C,T,A	1023,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28054	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4106	852.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1983	1983	A	1126	A,G	1125,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28054	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4106	852.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2617	2617	C	995	C,T,G	992,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28054	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4106	852.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2691	2691	A	969	A,G,T	967,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28054	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4106	852.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3243	3243	C	1023	C,T,A	1020,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2226	folP	855	855	100.0	folP.l15.c4.ctg.1	2165	128.3	1	SNP	p	R229S	0	.	.	685	687	CGC	1367	1369	CGC	222;223;221	C,T,A;G;C	220,1,1;223;221	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5632	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3795	184.9	1	SNP	p	S91F	0	.	.	271	273	TCC	775	777	TCC	218;218;216	T;C;C,A	218;218;215,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5632	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3795	184.9	1	SNP	p	D95N	0	.	.	283	285	GAC	787	789	GAC	217;217;220	G,T;A;C	216,1;217;220	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5632	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3795	184.9	1	SNP	p	D95G	0	.	.	283	285	GAC	787	789	GAC	217;217;220	G,T;A;C	216,1;217;220	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	2004	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1800	138.8	1	SNP	p	G45D	1	.	.	133	135	GAC	728	730	GAC	240;240;241	G;A,T,C;C	240;238,1,1;241	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1170	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1655	88.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5482	parC	2304	2304	99.83	parC.l6.c17.ctg.1	3436	199.1	1	SNP	p	D86N	0	.	.	256	258	GAC	862	864	GAC	230;229;230	G;A,G;C,A,G	230;227,2;228,1,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5482	parC	2304	2304	99.83	parC.l6.c17.ctg.1	3436	199.1	1	SNP	p	S88P	0	.	.	262	264	TCC	868	870	TCC	235;237;237	T;C,T;C,G	235;236,1;236,1	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4602	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3127	183.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1796	1798	GGC	242;239;236	G;G,C;C	242;238,1;235	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4366	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3000	181.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1561	1563	GCA	266;263;265	G;C;A,G	266;263;264,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4366	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3000	181.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1564	1566	ATC	264;265;266	A;T;C	264;265;266	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4366	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3000	181.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1576	1578	GTG	255;255;252	G;T,C,G;G	255;253,1,1;252	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4366	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3000	181.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1576	1578	GTG	255;255;252	G;T,C,G;G	255;253,1,1;252	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4366	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3000	181.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2080	2082	ACC	253;251;250	A;C;C,T	253;251;249,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4366	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3000	181.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2134	2136	GCG	213;214;213	G;C,G;G	213;213,1;213	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4366	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3000	181.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2134	2136	GCG	213;214;213	G;C,G;G	213;213,1;213	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4366	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3000	181.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2257	2259	GGC	252;250;251	G,C;G,T;C,A	251,1;249,1;250,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4366	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3000	181.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2266	2268	GGC	254;259;257	G;G;C	254;259;257	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4366	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3000	181.6	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2284	2286	CTG	247;246;244	C,G;T;G,A	246,1;246;243,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5990	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3609	207.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1878	1880	CCG	245;245;244	C,G;C;G	244,1;245;244	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2654	porA	1146	1146	99.83	porA.l15.c30.ctg.1	2363	140.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	592	594	GGC	196;194;194	G,T;G;C	195,1;194;194	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2654	porA	1146	1146	99.83	porA.l15.c30.ctg.1	2363	140.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	774	774	C	166	C	166	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	0	.	p	.	0	D41G	NONSYN	121	123	GAC	698	700	GGC	270;270;272	G,T;G;C	269,1;270;272	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	0	.	p	.	0	G120R	NONSYN	358	360	GGC	935	937	AGG	288;290;290	A;G;G,C	288;290;289,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	1004	1006	CAA	287;285;286	C;A;A	287;285;286	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1211	1213	GAT	293;294;295	G;A;T	293;294;295	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1214	1216	GAT	297;293;291	G;A;T	297;293;291	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	0	.	p	.	0	Q214H	NONSYN	640	642	CAA	1217	1219	CAT	288;287;285	C;A;T	288;287;285	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1220	1222	GCT	281;279;276	G;CTT,CT;T	281;274,1;276	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1229	1231	ATG	286;284;283	A;T;G	286;284;283	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1346	1348	ACG	230;232;232	A;C;G	230;232;232	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1352	1354	GTT	228;226;229	G,C,T;T;T	226,1,1;226;229	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	1	SNP	p	D121N	0	.	.	361	363	GAC	938	940	GAC	292;292;287	G,T;A;C	291,1;292;287	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3300	porB1b	1047	1047	98.85	porB1b.l15.c4.ctg.1	2149	191.3	1	SNP	p	A121D	1	.	.	361	363	GAC	938	940	GAC	292;292;287	G,T;A;C	291,1;292;287	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10984	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5381	255.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1678	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1585	132.2	1	SNP	p	V57M	1	.	.	169	171	ATG	789	791	ATG	303;305;305	A;T,A;G	303;304,1;305	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
